This project has been flagged by a community member as inappropriate due to reason below.*

Survey

Slingshot members are conducting a survey! The topic is:

Quarterly Survey: Continuous Glucose Monitoring Systems and Insulin Pumps Usage Trends and Preferences October 2023

Ticker(s): SENS, MDT, ABT, DXCM, PODD, TNDM

Who's being surveyed?

Survey Results include 20 Endocrinologists

Survey Questions
Q1.

How many patients with Diabetes are in your practice?

Q2.

How many of your patients do you consider eligible for a continuous glucose monitoring (CGM) device system?

Q3.

How many patients started using a CGM device system for the first time in the last 30 days?

Q4.

How many patients switched from one CGM device system to a new CGM device system in the last 30 days?

Q5.

How many patients do you anticipate will start using a CGM device system in the next 30 days?

Q6.

How much do you anticipate the volume of CGM device system usage to increase (by %), if at all, over the following?

  • 1 year
  • 3 years
  • 5 years

Q7.

What is the percentage breakdown of CGM device system brands you currently use? Please specify between 0-100 for each (sum to 100%).

  • Dexcom 
  • Eversense 
  • FreeStyle Libre 
  • Guardian Connect 
  • Other

Q8.

Which of the following brands is your preferred CGM device?

  • Dexcom
  • Eversense
  • FreeStyle Libre
  • Guardian Connect
  • Other

Q9.

Why is this your preferred CGM device?

Q10.

What features being added to future generation CGM devices would have you consider switching manufacturers or significantly shifting share? Please be specific.

Q11.

What % of your patients on a CGM are also currently using an insulin pump?

Q12.

What is the percentage breakdown of insulin pump brands you currently use? Please specify between 0-100 for each (sum to 100%).

  • Medtronic MiniMed 
  • Insulet: Omnipod Dash 
  • Insulet: Omnipod 5
  • Tandem t:slim X2 
  • Other

Q13.

Which of the following brands is your preferred insulin pump brand?

  • Medtronic MiniMed
  • Insulet: Omnipod Dash
  • Insulet: Omnipod 5
  • Tandem t:slim X2
  • Other

Q14.

In response to your answer above, why is this your preferred insulin pump brand?

Q15.

How have recent insurance coverage changes impacted your brand recommendation? Please be specific.

Q16.

How have recent insurance coverage changes impacted your brand recommendation? Please be specific.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.